In 1990, Dr. David K. Shefrin, ND, looked at the hormone support options available to his patients and saw the same frustrating pattern: oral formulations that had to survive stomach acid, first-pass liver metabolism, and variable intestinal absorption before delivering a fraction of their labeled dose to the tissues that actually needed them. His solution was to stop routing hormones through the digestive obstacle course entirely. Bezwecken was built on the principle that delivery route matters as much as the compound itself. Their signature Ovals bypass the GI tract completely, delivering bio-identical hormones directly to vaginal and rectal mucosa where absorption is rapid and liver metabolism is avoided. Their topical creams and transdermal oils put active compounds directly at the tissue level. Over 30 years later, the company still manufactures everything in-house at their Wilsonville, Oregon facility, still exceeds FDA cGMP requirements. The name is Dutch. It means "to aim for." What they aimed for was making the delivery system as intelligent as the formula inside it. Browse the categories below.
